RSH (ASX) Ann: Respiri progresses CE Mark registration

Originally posted by Richney: ↑

Hi Cabe,
There are also plenty of companies I am sure who utilised the advice from experts to complement their internal experience and have gone on to very successful and profitable futures, including clients of Lida and MC Saatchi. There is no problem with constructing a profile or building expectation or interest however the timing of it is crucial to get most leverage and impact to intended consumers and the market. This is not up to shareholders to decide, it is up to the company and the specialists they have engaged. Whether this is a slow burn ("Look out its coming") or a short sharp ("viral") strategy or something else will be dictated the by the market research, product, market channel, end consumer/target market etc. The company has both B2B (Hospitals, Governments, NHS, etc) and B2C channels through which they will be distributing and selling their products. Whilst a social media presence/campaign may be a relevant tool for B2C, it is irrelevant to B2B as they will do their own marketing through the channel. As per the previous announcements, the company has already embarked upon a "Register your Interest Campaign" through Lida who are consumer marketing specialists and have generated the fantastic market research results and engagement in UK, Australia and Singapore that was Announced last year. The company has also been very successful in engaging the medical community through Professor Bruce Thompson and the clinical studies that are being conducted that will continue to develop advocacy. This is further evidenced by the announcement today of the involvement of Professor Frank Thien who, in addition to Professor Bruce Thompson, are very powerful Key Opinion leaders (like Instagram influencers) who will drive advocacy and adoption of the Company's world leading technology. This will be the most important "marketing" that the company will do to ensure a successful launch and not social media presence only. I am sure the Company has a carefully timed program of consumer engagement that has been developed in consultation with specialists that will coincide with the regulatory approvals, clinical studies outcomes, Key Opinion leaders engagement and partnerships to get most leverage and benefit at the most appropriate time. The announcement today proves also that the company continues to de-risk its product so that the product to be launched will be the very highest standard and quality. We should take confidence in this process that a little bit more time has continued to de-risk the product which has enabled the likes of Professor Frank Thien to be confident of putting his name to the technology! This will only increase the value of the company over the long-term.

Expand

Well said again Richney - I have no interest in a philosophical debate, you are not saying anything wrong IMO - but batting this back and forth to try and justify or explain why, any number of scenarios could have been as effective as any number of others, is a futile waste of time.

We clearly agree in the positive prospects - but I do tend to keep an eye on the market - and according to; "that which is ALWAYS right" there is something very wrong - or at least, a substantial number of players that do not agree with the companies activity towards commercialisation!

GLTA and regards

Cabe

No.	Vol.	Price($)
1	17000	2.7¢

No.

Vol.

Price($)

17000

2.7¢

Price($)	Vol.	No.
3.0¢	292869	1

Price($)

Vol.

No.

3.0¢

292869

No.	Vol.	Price($)
1	17000	0.027
2	403524	0.026
3	800000	0.025
2	26816	0.021
2	1200000	0.020

No.

Vol.

Price($)

17000

0.027

403524

0.026

800000

0.025

26816

0.021

1200000

0.020

Price($)	Vol.	No.
0.030	292869	1
0.031	4450000	2
0.032	615000	5
0.033	18333	1
0.034	400000	1

Price($)

Vol.

No.

0.030

292869

0.031

4450000

0.032

615000

0.033

18333

0.034

400000

(20min delay)
Last 3.0¢		Change 0.003(11.1%)		Mkt cap ! $34.39M

Open	High	Low	Value	Volume
2.7¢	3.0¢	2.6¢	$14.17K	507.4K

Well said again Richney - I have no interest in a philosophical...

Brightstar tops votes in 2024 Kalgoorlie Super PITch

RBA keeps rates steady at 4.35%, reflecting expectations

Revolutionary inverter technology leads the clean energy charge

From the Floor with Kim Beazley at Diggers and Dealers 2024

From the Floor with Federal Opposition Leader Peter Dutton at Diggers & Dealers 2024

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Well said again Richney - I have no interest in a philosophical...

Top Stories

Brightstar tops votes in 2024 Kalgoorlie Super PITch

RBA keeps rates steady at 4.35%, reflecting expectations

Revolutionary inverter technology leads the clean energy charge

From the Floor with Kim Beazley at Diggers and Dealers 2024

From the Floor with Federal Opposition Leader Peter Dutton at Diggers & Dealers 2024

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News